what is acceptable blood sugar level

ūüĒ•+ what is acceptable blood sugar level 27 May 2020 Diabetes is a term used to describe a group of diseases marked by high levels of sugar (or glucose) in the blood (also known as hyperglycemia). Depending on ...

what is acceptable blood sugar level Hypoglycemia in infants is when the level of glucose in the blood is too low. Glucose is a type of sugar that the body uses for energy. The body cannot work the ...

diabetes rates by country type 2
[Skip to Content]
JAMA NeurologyJAMA Neurology
what is acceptable blood sugar level rash (‚≠źÔłŹ symptoms in children) | what is acceptable blood sugar level paperhow to what is acceptable blood sugar level for Sign In
Individual Sign In
Sign inCreate an Account
Institutional Sign In
OpenAthens Shibboleth
    [Skip to Content Landing]
    Figure 1.  Data Available on Migraine and Follow-up Summary

    Years were those in which information on migraine questions was recorded on self-reported questionnaires.

    Figure 2.  Evolution of the 2-Year Prevalence of Active Migraine Before and After Diagnosis of Type 2 Diabetes

    The graph shows a secondary analysis of data from 1992 to 2014 on 4371 women with type 2 diabetes in the E3N Cohort Study. The prevalences of migraine and their 95% CIs have been estimated from a generalized estimating equations model from 24 years prior to 22 years after type 2 diabetes diagnosis. Year 0 is the date of type 2 diagnosis. Models were adjusted for age, level of education, family history of diabetes, body mass index, smoking status, hypertension, level of recreational physical activity, use of oral contraceptives, menopausal status, menopausal hormone therapy use, and handedness.

    1.
    Vos  T, Flaxman  AD, Naghavi  M,  et al.  Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010  [published correction appears in Lancet. 2013;381(9867):628].  Lancet. 2012;380(9859):2163-2196. doi:10.1016/S0140-6736(12)61729-2PubMedGoogle ScholarCrossref
    2.
    Burch  RC, Loder  S, Loder  E, Smitherman  TA.  The prevalence and burden of migraine and severe headache in the United States: updated statistics from government health surveillance studies.  Headache. 2015;55(1):21-34. doi:10.1111/head.12482PubMedGoogle ScholarCrossref
    3.
    Scher  AI, Buse  DC, Fanning  KM,  et al.  Comorbid pain and migraine chronicity: the Chronic Migraine Epidemiology and Outcomes study.  Neurology. 2017;89(5):461-468. doi:10.1212/WNL.0000000000004177PubMedGoogle ScholarCrossref
    4.
    Goadsby ¬†PJ, Lipton ¬†RB, Ferrari ¬†MD. ¬†Migraine‚ÄĒcurrent understanding and treatment.¬†¬†N Engl J Med. 2002;346(4):257-270. doi:10.1056/NEJMra010917PubMedGoogle ScholarCrossref for 1 last update 27 May 2020
    5.
    Silberstein  SD.  Migraine.  Lancet. 2004;363(9406):381-391. doi:10.1016/S0140-6736(04)15440-8PubMedGoogle ScholarCrossref the 1 last update 27 May 2020
    6.
    Pavlovic  JM, Vieira  JR, Lipton  RB, Bond  DS.  Association between obesity and migraine in women.  Curr Pain Headache Rep. 2017;21(10):41. doi:10.1007/s11916-017-0634-8PubMedGoogle ScholarCrossref
    7.
    Pressman ¬†A, Jacobson ¬†A, Eguilos ¬†R, ¬†et al. ¬†Prevalence of migraine in a diverse community‚ÄĒelectronic methods for migraine ascertainment in a large integrated health plan.¬†¬†Cephalalgia. 2016;36(4):325-334. doi:10.1177/0333102415590242PubMedGoogle ScholarCrossref
    8.
    Scher  AI, Terwindt  GM, Picavet  HSJ, Verschuren  WMM, Ferrari  MD, Launer  LJ.  Cardiovascular risk factors and migraine: the GEM population-based study.  Neurology. 2005;64(4):614-620. doi:10.1212/01.WNL.0000151857.43225.49PubMedGoogle ScholarCrossref
    9.
    Rist  PM, Winter  AC, Buring  JE, Sesso  HD, Kurth  T.  Migraine and the risk of incident hypertension among women.  Cephalalgia. 2018;38(12):1817-1824. doi:10.1177/0333102418756865PubMedGoogle ScholarCrossref
    10.
    Rist ¬†PM, Tzourio ¬†C, Kurth ¬†T. ¬†Associations between lipid levels and migraine: cross-sectional analysis in the epidemiology of vascular ageing study.¬†¬†Cephalalgia. 2011;31(14):1459-1465. doi:10.1177/0333102411421682PubMedGoogle ScholarCrossrefwhat is acceptable blood sugar level treatment and prevention (‚≠źÔłŹ age of onset) | what is acceptable blood sugar level infohow to what is acceptable blood sugar level for
    11.
    Kurth  T, Slomke  MA, Kase  CS,  et al.  Migraine, headache, and the risk of stroke in women: a prospective study.  Neurology. 2005;64(6):1020-1026. doi:10.1212/01.WNL.0000154528.21485.3APubMedGoogle ScholarCrossref
    12.
    Spector  JT, Kahn  SR, Jones  MR, Jayakumar  M, Dalal  D, Nazarian  S.  Migraine headache and ischemic stroke risk: an updated meta-analysis.  Am J Med. 2010;123(7):612-624. doi:10.1016/j.amjmed.2009.12.021PubMedGoogle ScholarCrossref
    13.
    Adelborg  K, Szépligeti  SK, Holland-Bill  L,  et al.  Migraine and risk of cardiovascular diseases: Danish population based matched cohort study.  BMJ. 2018;360:k96. doi:10.1136/bmj.k96PubMedGoogle ScholarCrossref
    14.
    Kurth  T, Gaziano  JM, Cook  NR, Logroscino  G, Diener  H-C, Buring  JE.  Migraine and risk of cardiovascular disease in women.  JAMA. 2006;296(3):283-291. doi:10.1001/jama.296.3.283PubMedGoogle ScholarCrossref
    15.
    Kurth  T, Winter  AC, Eliassen  AH,  et al.  Migraine and risk of cardiovascular disease in women: prospective cohort study.  BMJ. 2016;353:i2610. doi:10.1136/bmj.i2610PubMedGoogle ScholarCrossref
    16.
    McCarthy  LC, Hosford  DA, Riley  JH,  et al.  Single-nucleotide polymorphism alleles in the insulin receptor gene are associated with typical migraine.  Genomics. 2001;78(3):135-149. doi:10.1006/geno.2001.6647PubMedGoogle ScholarCrossref
    17.
    Rainero  I, Limone  P, Ferrero  M,  et al.  Insulin sensitivity is impaired in patients with migraine.  Cephalalgia. 2005;25(8):593-597. doi:10.1111/j.1468-2982.2005.00928.xPubMedGoogle ScholarCrossref
    18.
    Cavestro  C, Rosatello  A, Micca  G,  et al.  Insulin metabolism is altered in migraineurs: a new pathogenic mechanism for migraine?  Headache. 2007;47(10):1436-1442. doi:10.1111/j.1526-4610.2007.00719.xPubMedGoogle ScholarCrossref
    19.
    Horev  A, Wirguin  I, Lantsberg  L, Ifergane  G.  A high incidence of migraine with aura among morbidly obese women.  Headache. 2005;45(7):936-938. doi:10.1111/j.1526-4610.2005.05162.xPubMedGoogle ScholarCrossref
    20.
    Peterlin  BL, Rapoport  AM, Kurth  T.  Migraine and obesity: epidemiology, mechanisms, and implications.  Headache. 2010;50(4):631-648. doi:10.1111/j.1526-4610.2009.01554.xPubMedGoogle ScholarCrossref
    21.
    Antonazzo  IC, Riise  T, Cortese  M,  et al.  Diabetes is associated with decreased migraine risk: a nationwide cohort study.  Cephalalgia. 2018;38(11):1759-1764.PubMedGoogle ScholarCrossref the 1 last update 27 May 2020
    22.
    Burch  RC, Rist  PM, Winter  AC,  et al.  Migraine and risk of incident diabetes in women: a prospective study.  Cephalalgia. 2012;32(13):991-997. doi:10.1177/0333102412453954PubMedGoogle ScholarCrossref
    23.
    Clavel-Chapelon  F; E3N Study Group.  Cohort profile: the French E3N cohort study.  Int J Epidemiol. 2015;44(3):801-809. doi:10.1093/ije/dyu184PubMedGoogle ScholarCrossref
    24.
    Kengne  AP, Beulens  JWJ, Peelen  LM,  et al.  Non-invasive risk scores for prediction of type 2 diabetes (EPIC-InterAct): a validation of existing models.  Lancet Diabetes Endocrinol. 2014;2(1):19-29. doi:10.1016/S2213-8587(13)70103-7PubMedGoogle ScholarCrossref
    25.
    Mancini  FR, Dow  C, Affret  A,  et al.  Micronutrient dietary patterns associated with type 2 diabetes mellitus among women of the E3N-EPIC (Etude Epidémiologique Auprès de Femmes de l’Education Nationale) cohort study.  J Diabetes. 2018;10(8):665-674. doi:10.1111/1753-0407.12654PubMedGoogle ScholarCrossref
    26.
    Bonnet  F, Affret  A, Boutron-Ruault  M-C, Balkau  B, Clavel-Chapelon  F, Fagherazzi  G.  Association between handedness and type 2 diabetes: the E3N study.  Diabetes Care. 2015;38(12):e199. doi:10.2337/dc15-1669PubMedGoogle ScholarCrossref for 1 last update 27 May 2020
    27.
    Lipsitz  SR, Kim  K, Zhao  L.  Analysis of repeated categorical data using generalized estimating equations.  Stat Med. 1994;13(11):1149-1163. doi:10.1002/sim.4780131106PubMedGoogle ScholarCrossref
    28.
    Hockaday  JM, Williamson  DH, Whitty  CWM.  Blood-group levels and fatty-acid metabolism in migraine related to fasting.  Lancet. 1971;1(7710):1153-1156. doi:10.1016/S0140-6736(71)91662-XPubMedGoogle ScholarCrossref
    29.
    Marsters  JB, Mortimer  MJ, Hay  KM.  Glucose and diet in the fasting migraineur.  Headache. 1986;26(5):243-247. doi:10.1111/j.1526-4610.1986.hed2605243.xPubMedGoogle ScholarCrossref
    30.
    Critchley  M, Ferguson  F.  Migraine.  Lancet. 1933;221(5708):123-126. doi:10.1016/S0140-6736(00)84315-9Google ScholarCrossref
    31.
    Dexter  JD, Roberts  J, Byer  JA.  The five hour glucose tolerance test and effect of low sucrose diet in migraine.  Headache. 1978;18(2):91-94. doi:10.1111/j.1526-4610.1978.hed1802091.xPubMedGoogle ScholarCrossref
    32.
    Kokavec  A.  Effect of sucrose consumption on serum insulin, serum cortisol and insulin sensitivity in migraine: evidence of sex differences.  Physiol Behav. 2015;142:170-178. doi:10.1016/j.physbeh.2015.02.022PubMedGoogle ScholarCrossref
    33.
    Vollesen ¬†ALH, Snoer ¬†A, Beske ¬†RP, ¬†et al. ¬†Effect of infusion of calcitonin gene-related peptide on cluster headache attacks: a randomized clinical trial.¬†¬†JAMA Neurol. 2018;75(10):1187-1197. doi:10.1001/jamaneurol.2018.1675PubMedGoogle ScholarCrossrefwhat is acceptable blood sugar level range chart (‚ėĎ vision) | what is acceptable blood sugar level medicine which aetna pays forhow to what is acceptable blood sugar level for
    34.
    Enr√≠quez-P√©rez ¬†IA, Galindo-Ordo√Īez ¬†KE, Pantoja-Ort√≠z ¬†CE, ¬†et al. ¬†Streptozocin-induced type-1 diabetes mellitus results in decreased density of CGRP sensory and TH sympathetic nerve fibers that are positively correlated with bone loss at the mouse femoral neck.¬†¬†Neurosci Lett. 2017;655:28-34. doi:10.1016/j.neulet.2017.06.042PubMedGoogle ScholarCrossref
    35.
    Li  T-P, Guo  Z, Liu  C-J, Sun  T, Chen  L, Zhao  X.  Association of down-regulation of calcitonin gene-related peptide and substance P with increase of myocardial vulnerability in diabetic neuropathic rats.  Peptides. 2017;96:1-7. doi:10.1016/j.peptides.2017.08.007PubMedGoogle ScholarCrossref for 1 last update 27 May 2020
    36.
    Molina  JM, Cooper  GJ, Leighton  B, Olefsky  JM.  Induction of insulin resistance in vivo by amylin and calcitonin gene-related peptide.  Diabetes. 1990;39(2):260-265. doi:10.2337/diab.39.2.260PubMedGoogle ScholarCrossref
    37.
    Abbasi ¬†A, Corpeleijn ¬†E, Postmus ¬†D, ¬†et al. ¬†Plasma procalcitonin is associated with obesity, insulin resistance, and the metabolic syndrome.¬†¬†J Clin Endocrinol Metab. 2010;95(9):E26-E31. doi:10.1210/jc.2010-0305PubMedGoogle ScholarCrossrefwhat is acceptable blood sugar level treatment nice (‚≠źÔłŹ fruits) | what is acceptable blood sugar level meal planhow to what is acceptable blood sugar level for
    38.
    Siva  ZO, Uluduz  D, Keskin  FE,  et al.  Determinants of glucose metabolism and the role of NPY in the progression of insulin resistance in chronic migraine.  Cephalalgia. 2018;38(11):1773-1781.PubMedGoogle ScholarCrossref
    39.
    Wang ¬†X, Li ¬†X, Diao ¬†Y, ¬†et al. ¬†Are glucose and insulin metabolism and diabetes associated with migraine? a community-based, case-control study.¬†¬†J Oral Facial Pain Headache. 2017;31(3):240-250. doi:10.11607/ofph.1843PubMedGoogle ScholarCrossrefwhat is acceptable blood sugar level cookbook (‚ėĎ example) | what is acceptable blood sugar level therapeutichow to what is acceptable blood sugar level for

    Others Also Liked

    Select Your Interests

    Select Your Interests

    Customize your JAMA Network experience by selecting one or more topics from the list below.

    • Acid Base, Electrolytes, Fluids
    • Allergy
    • Allergy and Clinical Immunology
    • Anesthesiology
    • Anticoagulation
    • what is acceptable blood sugar level hereditary (ūüĎć lipid) | what is acceptable blood sugar level sugar levelhow to what is acceptable blood sugar level for Art of the JAMA for 1 last update 27 May 2020 NetworkArt of the JAMA Network
    • Bleeding and Transfusion
    • Cardiology
    • Caring for the Critically Ill Patient
    • Challenges in Clinical Electrocardiography
    • what is acceptable blood sugar level glucagon (ūüĒ• and headache) | what is acceptable blood sugar level is caused byhow to what is acceptable blood sugar level for Clinical Challenge
    • Clinical Decision Support
    • Clinical Implications of Basic Neuroscience
    • Clinical Pharmacy and Pharmacology
    • what is acceptable blood sugar level treatment options (ūüĒī food chart) | what is acceptable blood sugar level glucose levelshow to what is acceptable blood sugar level for Complementary and Alternative Medicine
    • what is acceptable blood sugar level ankle swelling (ūüĎć treatment and prevention) | what is acceptable blood sugar level doctor near mehow to what is acceptable blood sugar level for Consensus Statements
    • Coronavirus (COVID19)
    • Critical Care Medicine
    • Dental Medicine
    • Dermatology
    • Diabetes and Endocrinology
    • Drug Development
    • Electronic Health Records
    • Emergency Medicine
    • End of Life
    • Environmental Health
    • Ethics
    • Facial Plastic Surgery
    • Foodborne for 1 last update 27 May 2020 IllnessFoodborne Illness
    • Gastroenterology and Hepatology
    • Genetics and Genomics
    • Genomics and Precision Health
    • the 1 last update 27 May 2020 GeriatricsGeriatrics
    • Global Health
    • Guide to Statistics and Medicine
    • what is acceptable blood sugar level mellitus (ūüĒī young) | what is acceptable blood sugar level ketones in urinehow to what is acceptable blood sugar level for Guidelines
    • Hair Disorders
    • Health Care Delivery Models
    • Health Care Economics, Insurance, Payment
    • Health Care Policy
    • Health Care Quality
    • what is acceptable blood sugar level statistics australia (ūüĎć untreated) | what is acceptable blood sugar level blood testhow to what is acceptable blood sugar level for Health Care Reform
    • Health Care Safety
    • Health Care for 1 last update 27 May 2020 WorkforceHealth Care Workforce
    • Health Disparities
    • Health Informatics
    • Health Policy
    • Hematology
    • History of Medicine
    • for 1 last update 27 May 2020 HumanitiesHumanities
    • Hypertension
    • Images in Neurology
    • Imaging
    • Immunology
    • Implementation Science
    • what is acceptable blood sugar level and headache (ūüĎć epidemiology) | what is acceptable blood sugar level termhow to what is acceptable blood sugar level for Infectious Diseases
    • Innovations in Health Care Delivery
    • JAMA Infographic
    • Law and Medicine
    • Leading Change
    • Less is More
    • what is acceptable blood sugar level insulin resistance (‚≠źÔłŹ treatment side effect) | what is acceptable blood sugar level treatment without medicationhow to what is acceptable blood sugar level for Lifestyle Behaviors
    • Medical Coding
    • Medical Devices and Equipment
    • Medical Education
    • what is acceptable blood sugar level edema (ūüĒī diet plan examples) | what is acceptable blood sugar level neuropathyhow to what is acceptable blood sugar level for Medical Education and Training
    • Medical Journals and Publishing
    • Melanoma
    • Mobile Health and Telemedicine
    • Narrative Medicine
    • Nephrology
    • what is acceptable blood sugar level uptodate (‚ėĎ in hindi) | what is acceptable blood sugar level treatment home remedieshow to what is acceptable blood sugar level for Neurology
    • what is acceptable blood sugar level recipes (ūüĎć health promotion) | what is acceptable blood sugar level drugshow to what is acceptable blood sugar level for Neuroscience the 1 last update 27 May 2020 and PsychiatryNeuroscience and Psychiatry
    • Notable Notes
    • Nursing
    • Nutrition
    • Nutrition, Obesity, Exercise
    • Obesity
    • Obstetrics and the 1 last update 27 May 2020 GynecologyObstetrics and Gynecology
    • Occupational Health
    • Oncology
    • Ophthalmic Images
    • Ophthalmology
    • Orthopedics
    • Otolaryngology
    • Pain Medicine
    • Pathology and Laboratory Medicine
    • Patient Care
    • Patient Information
    • Pediatrics
    • what is acceptable blood sugar level joint pain (ūüĎć medicine which aetna pays for) | what is acceptable blood sugar level webmdhow to what is acceptable blood sugar level for Performance Improvement
    • Performance Measures
    • Perioperative Care and Consultation
    • what is acceptable blood sugar level test kit (‚≠źÔłŹ quality of life) | what is acceptable blood sugar level eggshow to what is acceptable blood sugar level for Pharmacoeconomics
    • the 1 last update 27 May 2020 PharmacoepidemiologyPharmacoepidemiology
    • Pharmacogenetics
    • Pharmacy and Clinical Pharmacology
    • Physical Medicine and the 1 last update 27 May 2020 RehabilitationPhysical Medicine and Rehabilitation
    • Physical Therapy
    • Physician Leadership
    • Poetry
    • Population Health
    • Professional Well-being
    • Professionalism
    • Psychiatry
    • what is acceptable blood sugar level nurse teaching (‚ėĎ symptoms nhs) | what is acceptable blood sugar level blood pressurehow to what is acceptable blood sugar level for Public Health
    • Pulmonary Medicine
    • Radiology
    • Regulatory Agencies
    • Research, Methods, Statistics
    • for 1 last update 27 May 2020 ResuscitationResuscitation
    • Rheumatology
    • Scientific Discovery and the Future of Medicine
    • Shared Decision Making and Communication
    • what is acceptable blood sugar level gene (ūüĒ• diagnosis) | what is acceptable blood sugar level risehow to what is acceptable blood sugar level for Sleep Medicine
    • Sports the 1 last update 27 May 2020 MedicineSports Medicine
    • what is acceptable blood sugar level yo mama (‚≠źÔłŹ home remedies) | what is acceptable blood sugar level obesehow to what is acceptable blood sugar level for Statistics and Research Methods
    • Stem Cell Transplantation
    • Substance Use and Addiction
    • Surgery
    • Surgical Innovation
    • Surgical for 1 last update 27 May 2020 PearlsSurgical Pearls
    • Teachable Moment
    • Technology and Finance
    • The Rational Clinical Examination
    • Tobacco and e-Cigarettes
    • Toxicology
    • Trauma and Injury
    • Treatment Adherence
    • United States Preventive Services Task Force
    • for 1 last update 27 May 2020 UrologyUrology
    • Users' Guide to the Medical Literature
    • Vaccination
    • Venous Thromboembolism
    • Veterans Health
    • Violence
    • Women's Health
    • Workflow and Process
    • Wound Care, Infection, Healing
    Save Preferences
    for 1 last update 27 May 2020 what is acceptable blood sugar level hba1c (‚ėĎ google scholar) | what is acceptable blood sugar level lawsuithow to what is acceptable blood sugar level for
    Original Investigation
    December 17, 2018
    Author Affiliations Article Information
    • 1Center for Research in Epidemiology and Population Health, UMR 1018, Institut National de la Sant√© et de la Recherche M√©dicale (INSERM) U1018, Paris-South Paris Saclay University, Gustave Roussy Institute, Villejuif, France
    • 2Paris‚ÄďSouth Paris Saclay University, Villejuif, France
    • 3Center for Research in Epidemiology and Population Health, UMR 1018, Institut National de la Sant√© et de la Recherche M√©dicale (INSERM), Versailles Saint Quentin University, Villejuif, France
    • 4Institute of Public Health Charit√©‚ÄďUniversit√§tsmedizin Berlin, Berlin, Germany
    • 5Centre Hospitalier Universitaire de Rennes, Universit√© de Rennes 1, Rennes, France
    JAMA Neurol. 2019;76(3):257-263. doi:10.1001/jamaneurol.2018.3960
    Key Points

    Questions  Is there an association between migraine and type 2 diabetes in women?

    Findings¬† In this study of for 1 last update 27 May 2020 74‚ÄĮ247 women in a French national cohort, a lower risk of type 2 diabetes was observed in women with active migraine. We also found a linear decrease of migraine prevalence long before and a plateau long after type 2 diabetes diagnosis.Findings¬† In this study of 74‚ÄĮ247 women in a French national cohort, a lower risk of type 2 diabetes was observed in women with active migraine. We also found a linear decrease of migraine prevalence long before and a plateau long after type 2 diabetes diagnosis.

    Meaning  These results may suggest a potential role of both hyperglycemia and hyperinsulinism on migraine occurrence.

    Abstract

    what is acceptable blood sugar level hacks (‚≠źÔłŹ bracelet) | what is acceptable blood sugar level in childrenhow to what is acceptable blood sugar level for Importance¬† Little is known about the associations between migraine and type 2 diabetes and the temporality the 1 last update 27 May 2020 of the association between these 2 diseases.Little is known about the associations between migraine and type 2 diabetes and the temporality of the association between these 2 diseases.

    Objective  To evaluate the association between migraine and type 2 diabetes incidence as well as the evolution of the prevalence of active migraine before and after type 2 diabetes diagnosis.

    Design, Setting, and Participants  We used data from the E3N cohort study, a French prospective population-based study initiated in 1990 on a cohort of women born between 1925 and 1950. The E3N study participants are insured by a health insurance plan that mostly covers teachers. From the eligible women in the E3N study, we included those who completed the 2002 follow-up questionnaire with information available on migraine. We then excluded prevalent cases of type 2 diabetes, leaving a final sample of women who were followed up between 2004 and 2014. All potential occurrences of type 2 diabetes were identified through a drug reimbursement database. Statistical analyses were performed in March 2018.

    Exposures  Self-reported migraine occurrence.

    Main Outcomes and Measures  Pharmacologically treated type 2 diabetes.

    Results¬† From the 98‚ÄĮ995 women in the study, 76‚ÄĮ403 women completed the 2002 follow-up survey. Of these, 2156 were excluded because they had type 2 diabetes, leaving 74‚ÄĮ247 women. Participants had a mean (SD) age of 61 (6) years at baseline, and all were free of type 2 diabetes. During 10 years of follow-up, 2372 incident type 2 diabetes cases occurred. A lower risk of type 2 diabetes was observed for women with active migraine compared with women with no migraine history (univariate hazard ratio, 0.80 [95% CI, 0.67-0.96], multivariable-adjusted hazard ratio, 0.70 [95% CI, 0.58-0.85]). We also observed a linear decrease in active migraine prevalence from 22% (95% CI, 16%-27%) to 11% (95% CI, 10%-12%) during the 24 years prior to diabetes diagnosis, after adjustment for potential type 2 diabetes risk factors. A plateau of migraine prevalence around 11% was then observed for 22 years after diagnosis.

    Conclusions and Relevance  We observed a lower risk of developing type 2 diabetes for women with active migraine and a decrease in active migraine prevalence prior to diabetes diagnosis. Further targeted research should focus on understanding the mechanisms involved the 1 last update 27 May 2020 in explaining these findings.We observed a lower risk of developing type 2 diabetes for women with active migraine and a decrease in active migraine prevalence prior to diabetes diagnosis. Further targeted research should focus on understanding the mechanisms involved in explaining these findings.

    Introduction

    Quiz Ref IDMigraine is an intermittent painful neurologic headache disorder with an estimated 1-year prevalence of 15% to 18%1-5; it has been shown to be more common in women of reproductive age, with a declining prevalence after menopause.6,7 Previous work has shown that migraine, and especially migraine with aura, is associated with hyperlipidemia, hypertension, and an elevated Framingham Risk Score for coronary heart disease.8-10 Migraine has further been associated with increased risk of overall and specific cardiovascular disease events.11-15 Because migraine has also been associated with factors associated with insulin resistance and type 2 diabetes, an association between migraine and diabetes has been hypothesized. However, to our knowledge, data are scarce. Some previous articles have suggested an association between polymorphisms in the insulin receptor gene and migraine,16 impaired insulin sensitivity in individuals with migraine,17 and possibly elevated blood glucose and insulin levels in people with headaches,18 whereas others have shown that the frequency of migraine increased with body mass index,19 a major risk factor for type 2 diabetes. Indeed, it has been previously reported20 that chronic daily headache was increased in adults with obesity and the prevalence of episodic headaches may be increased in adults with obesity who are of reproductive age. However, despite the high prevalence of both diseases, the association between migraine and type 2 diabetes is still unclear.

    what is acceptable blood sugar level info (ūüĒī reversal) | what is acceptable blood sugar level diet plan printablehow to what is acceptable blood sugar level for Results from a population-based study in Norway have shown that people with type 1 or type 2 diabetes had a lower risk of migraine compared with the general population.21 Data from the Women‚Äôs Health Study did not find associations between migraine and incident diabetes.22 Moreover, little is known about the temporality of the potential association between migraine and type 2 diabetes.

    Therefore, we aimed to evaluate the associations between migraine and the risk of developing type 2 diabetes in the prospective E3N cohort study. We also aimed to determine how the likelihood of migraine changed in association with incidence of type 2 diabetes.

    Methods
    Study Population

    Quiz Ref IDThe Etude Epid√©miologique Aupr√®s des Femmes de la Mutuelle G√©n√©rale de l‚ÄôEducation Nationale (E3N) study is a French prospective cohort study, initiated in 1990, of 98‚ÄĮ995 women born between 1925 and 1950.23 The E3N study participants are insured by a health insurance plan that mostly covers teachers. The E3N study is the French component of the European Prospective Investigation into Cancer and Nutrition (EPIC) and is part of EPIC-InterAct, a case-cohort study on type 2 diabetes nested within EPIC.24 Participants have completed self-administered questionnaires that have been sent biennially since 1990. The mean response rate to a follow-up questionnaire is 83%, with a total loss to follow-up since 1990 of less than 3%. Furthermore, for each cohort member, the health insurance plan provided data that included all outpatient reimbursements for health expenditure since January 1, 2004; these data included brand names, dosages, and dates of drug purchases.

    The study was approved by the French National Commission for Data Protection and Privacy (ClinicalTrials.gov identifier: NCT03285230). All participants gave their written informed consent.

    Population for Analysis and Follow-up

    Follow-up surveying for this study started on April 1, 2004. Participants contributed person-years of follow-up until the date of diagnosis of type 2 diabetes, the date of the last completed questionnaire, or November 17, 2014 (the date at which the last E3N questionnaire used for this study was sent to participants), whichever occurred first. From the women in the E3N study, we included women who completed the 2002 follow-up questionnaire with information available on migraine. We then excluded prevalent cases of type 2 diabetes to define the final sample for this study.

    Assessment of Migraine and Migraine Medications

    Information on migraine episodes was asked in the questionnaires sent in 1992, 1993, 1995, 1997, 2000, 2002, 2005, and 2011 (Figure 1), similar to what has been done in other studies.14 We have been able to for 1 last update 27 May 2020 use all of this information to update the exposure at each questionnaire with 3 main categories: (1) no migraine history; (2) active migraine (ie, all women who self-reported migraine on the current questionnaire cycle); and (3) prior migraine (ie, women who reported experiencing migraine in at least 1 of the past questionnaires but not on the current questionnaire). Information on the presence of aura was unavailable.Information on migraine episodes was asked in the questionnaires sent in 1992, 1993, 1995, 1997, 2000, 2002, 2005, and 2011 (Figure 1), similar to what has been done in other studies.14 We have been able to use all of this information to update the exposure at each questionnaire with 3 main categories: (1) no migraine history; (2) active migraine (ie, all women who self-reported migraine on the current questionnaire cycle); and (3) prior migraine (ie, women who reported experiencing migraine in at least 1 of the past questionnaires but not on the current questionnaire). Information on the presence of aura was unavailable.

    We also controlled for the use of drugs frequently prescribed for migraine. These drugs were identified through the drug reimbursement database. We considered all reimbursements of drugs since April 1, 2004, corresponding to the World Health Organization Anatomical Therapeutic Chemical codes N02C (antimigraine preparations), M01A (nonsteroidal anti-inflammatory drugs and antirheumatic products), N02B (other analgesics and antipyretics), N03A (antiepileptics), N07C (antivertigo preparations), and C07 (ő≤-blocking agents). Exposures to both antimigraine preparations and other drugs potentially used to treat migraine were updated continuously between 2004 and 2014.

    Assessment of Type 2 Diabetes Cases

    We defined cases of type 2 diabetes if a participating woman was pharmacologically treated with type 2 diabetes‚Äďspecific medicationsQuiz Ref IDwhat is acceptable blood sugar level meal plan (ūüĒī would be considered) | what is acceptable blood sugar level meal planhow to what is acceptable blood sugar level for . All potential type 2 diabetes occurrences were identified through the drug reimbursement database: women reimbursed at least twice for glucose-lowering medications within a sliding period of 1 year were classified as having type 2 diabetes, with the date of diagnosis defined as the date of first reimbursement.25

    Statistical Analyses

    Baseline characteristics of the study population were described in the overall population and according to migraine history. We used Cox proportional hazards regression models with age as the time scale to estimate hazard ratios (HRs) and 95% CIs to evaluate the association of migraine and the risk of type 2 diabetes. Migraine was considered as a time-dependent variable in the Cox proportional hazards regression models and categorized as (1) no migraine history, (2) prior migraine, or (3) active migraine. During the follow-up surveys, we had 4% missing data on migraine in 2005 and 5% missing data in 2011. If data on migraine were missing, we used the last known data available (last observation carried forward method). Models were univariate and then further adjusted for a list of established type 2 diabetes risk factors or variables leading to potential confounding: level of education (undergraduate or less, graduate, postgraduate or more; at baseline), level of recreational physical activity (metabolic equivalent task‚Äďhours per week, as a continuous variable; at baseline), body mass index (calculated as weight in kilograms divided by height in meters squared; <20, 20-25, 25-30, ‚Č•30; time dependent), smoking status (nonsmoker, former smoker, or current smoker; time dependent), history of hypertension (no or yes; time dependent), menopausal status (premenopausal or postmenopausal; time dependent), menopausal hormone therapy use (never or ever; time dependent), use of oral contraceptives (never or ever; time dependent), family history of diabetes (no, yes, or unknown; at baseline), handedness (right-handed, left-handed, mixed, or unknown; at baseline),26 use of antimigraine preparations (current, past, or never; time dependent), and use of drugs other than antimigraine preparations frequently prescribed for migraine (current, past, or never; time dependent).

    In a secondary analysis of women who developed type 2 diabetes during the follow-up period, we investigated the evolution of the prevalence of active migraine with respect to the date of type 2 diabetes diagnosis. To do so, we analyzed 4371 women with type 2 diabetes cases that occurred between 1992 and 2014. Analyses were based on a possible 46-year window (from 24 years prior to the diagnosis to 22 years after) with year 0 as the year of diagnosis of type 2 diabetes. We used a repeated-measures logistic regression analysis by the generalized estimating equations method, with an autoregressive correlation structure.27 The method takes the intraindividual correlation between measurements into account and is robust to missing values. To plot the trajectory of self-reported migraine episodes in association with the years before diabetes diagnosis, odds ratios (ORs) and their 95% CIs were estimated each year and then converted into proportions. As for the Cox models, this model was adjusted for age, level of education, family history of diabetes, body mass index, smoking status, hypertension, level of recreational physical activity, use of oral contraceptives, menopausal status, menopausal hormone therapy use, and handedness.

    All statistical analyses used SAS version 9.4 (SAS Institute Inc) with the PHREG procedure used for Cox models and the GENMOD procedure for repeated-measures logistic regression. Missing values were less than 5% for all variables and were imputed with the median (quantitative variables) or the 1 last update 27 May 2020 the mode (qualitative variables) of the study population. All statistical tests were 2-sided, and we considered a P value less than .05 statistically significant. Figure 1 was plotted with the statistical software R version 3.1.0 (Free Software Foundation). Data analysis was completed in March 2018.All statistical analyses used SAS version 9.4 (SAS Institute Inc) with the PHREG procedure used for Cox models and the GENMOD procedure for repeated-measures logistic regression. Missing values were less than 5% for all variables and were imputed with the median (quantitative variables) or the mode (qualitative variables) of the study population. All statistical tests were 2-sided, and we considered a P value less than .05 statistically significant. Figure 1 was plotted with the statistical software R version 3.1.0 (Free Software Foundation). Data analysis was completed in March 2018.

    Results

    From a total of 98‚ÄĮ995 women in the E3N study, 76‚ÄĮ403 had provided the requisite data and were included. Another 2156 were excluded because of type 2 diabetes diagnoses at baseline, leaving 74‚ÄĮ247 women in the study analysis. Participants had a mean (SD) age of 61 (6) years on average at baseline. A total of 2372 participants experienced incident cases of type 2 diabetes between 2004 and 2014.

    Study Participant Characteristics

    what is acceptable blood sugar level natural treatment (ūüĒī mellitus is primarily a problem with) | what is acceptable blood sugar level fatiguehow to what is acceptable blood sugar level for When compared with women with no migraine history (Table 1), women who reported active migraine were younger (mean [SD] age: women with no migraine history, 61.8 [7] years; women with active migraine, 59.9 [6] years), had a lower level of physical activity (mean [SD] metabolic equivalent task‚Äďhours per week, 25.05 [21] vs 23.16 [20]), were more likely to have a family history of diabetes (5598 of 49‚ÄĮ199 [11.4%] vs 964 of 7839 [12.3%]), were more likely to use oral contraceptives (29‚ÄĮ142 of 49‚ÄĮ199 [59.2%] vs 5167 of 7839 [65.9%]), were more likely to have a body mass index less than 20(5907 of 49‚ÄĮ199 [12.0%] vs 1092 of 7839 [13.9%]), and were more likely to be former smokers (17‚ÄĮ359 of 49‚ÄĮ199 [35.6%] vs 3086 of 7839 [39.4%]). Compared with women with no migraine history, women with prior migraine were younger (mean [SD] age: women with no history of migraine, 61.8 [7] years; women with prior migraine, 60.9 [6] years) and were more likely to have a family history of diabetes (5598 of 49‚ÄĮ199 [11.4%] vs 2133 of 17‚ÄĮ209 [12.4%]), have a history of hypertension (22‚ÄĮ114 of 49‚ÄĮ199 [44.9%] vs 8921 of 17‚ÄĮ209 [51.8%]), use oral contraceptives (29‚ÄĮ142 of 49‚ÄĮ199 [59.2%] vs 10‚ÄĮ945 of 17‚ÄĮ209 [63.6%]), be overweight (11‚ÄĮ621 of 49‚ÄĮ199 [23.6%] vs 4218 of 17‚ÄĮ209 [24.5%]), and have never smoked (26‚ÄĮ721 of 49‚ÄĮ199 [54.3%] vs 1595 of 17‚ÄĮ209 [9.3%]).

    There was no difference in the baseline distribution of handedness with respect to migraine self-report. However, we found that women with a mixed or ambidextrous handedness were at increased risk of self-reporting migraine during the follow-up period (2004-2014) compared with right-handed women (OR, 1.13 [95% CI, 1.02-1.24]), whereas left-handed women were not (OR, 1.01 [95% CI, 0.88-1.16]).

    Migraine and Risk of Incident Type 2 Diabetes

    what is acceptable blood sugar level and coronavirus (ūüĎć life expectancy) | what is acceptable blood sugar level quizlethow to what is acceptable blood sugar level for Between 2004 and 2014, a total of 2372 women developed type 2 diabetes (Table 2). In univariate models, we observed a lower risk of incident type 2 diabetes in women with active migraine (HR, 0.80 [95% CI, 0.60-0.96]) than in women with no migraine history. The magnitude of this association increased in multivariable-adjusted models (HR, 0.70 [95% CI, 0.58-0.85]). Prior migraine was not associated with the risk of type 2 diabetes both in univariate models (HR, 1.16 [95% CI, 1.06-1.27]) and multivariable-adjusted models (HR, 1.07 [95% CI, 0.98-1.17]).

    Trends in the Proportion of Reported Active Migraine Before and After Type 2 Diabetes Diagnosis

    There was a clear linear decrease in the 2-year prevalence of active migraine from 24 years before diagnosis (22% [95% CI, 16%-27%]; Figure 2) to the date of diagnosis (11% [95% CI, 10%-12%]). After type 2 diabetes diagnosis, there was a plateau in the prevalence of active migraine (10% to 11%) that persisted up to 22 years after diagnosis. The magnitudes of the estimates were not sensitive to adjustment for time-varying covariates.

    Discussion

    Quiz Ref IDBased on data the 1 last update 27 May 2020 from this large prospective cohort of women, we report an inverse association between active migraine and type 2 diabetes incidence. Women with active migraine had an approximate 30% decrease in the risk of developing diabetes. We found a clear linear decrease in the prevalence of active migraine prior to type 2 diabetes diagnosis and a stagnation of migraine prevalence after diagnosis of diabetes.Quiz Ref IDBased on data from this large prospective cohort of women, we report an inverse association between active migraine and type 2 diabetes incidence. Women with active migraine had an approximate 30% decrease in the risk of developing diabetes. We found a clear linear decrease in the prevalence of active migraine prior to type 2 diabetes diagnosis and a stagnation of migraine prevalence after diagnosis of diabetes.

    Comparison With Previous Studies

    Despite the high prevalence of both diseases, to our knowledge, little is known about the association of migraine with type 2 diabetes at a population level. Migraine has been associated with factors that are implicated in diabetes; some previous publications have suggested an association between polymorphisms in the insulin receptor gene and migraine,16 an impaired insulin sensitivity in individuals with migraine,17 and possible elevations in blood glucose and insulin levels in people with headaches,18 whereas a cross-sectional study on 27 people19 showed that the frequency of migraine was high in individuals with obesity, a major risk factor for type 2 diabetes. A review20 published in 2010 summarizing 3 prospective cohort studies reported that, in both sexes, chronic daily headache was increased in adults with obesity and the prevalence of episodic headaches may also be increased in adults of reproductive age with obesity.

    Potential Mechanisms

    It has been proposed that a trigger for migraine could be nutritional, hormonal, or metabolic in some individuals. An association between polymorphisms in the insulin receptor gene and migraine has been shown.16 An elevation in free fatty acid plasma concentration and ketone bodies has also been reported before a migraine attack.28 Therefore, fasting could promote the development of migraine, mostly by favoring hypoglycemia and increased ketone bodies production.29 Hypoglycemia has long been known to be a precipitating factor in migraine onset.30 These biological factors could therefore explain an inverse association between migraine and type 2 diabetes risk. They could also support our observed decreased prevalence of migraine in the years before type 2 diabetes diagnosis, when there is usually a progressively increasing hyperglycemic state. Increased secretion of insulin after intake of carbohydrate and sucrose-rich meals may promote the occurrence of reactive hypoglycemia in some people, which may trigger migraine.31 In this regard, 1 study32 reported a higher level of plasma insulin in women with migraine compared with control participants.

    Quiz Ref IDIn addition, other mechanisms may be involved: calcitonin gene-related peptide (CGRP), a neuropeptide expressed in sensory nerves, which seems to play an important role in migraine pathophysiology,33 is also associated with glucose metabolism. It has been reported34 that rats with experimentally induced diabetes have a decreased density of CGRP sensory nerve fibers.

    In addition, CGRP is a well-established potent vasodilator and has a vascular protective role. In animal models, diabetic impairment of sensory nerves with reduced expression of CGRP has been reported.35 We may speculate that the vasodilation and the nociceptive effects induced by CGRP are impaired after diabetes appears, which may explain the reduced prevalence of active migraine. However, we cannot exclude that a factor associated with migraine pathophysiology may modulate glucose metabolism and have an influence on the appearance of hyperglycemia. The association between CGRP and glucose homeostasis is complex and bidirectional. Studies conducted predominantly in rats with obesity and type 2 diabetes have shown that infusion of pharmacological doses of CGRP induces insulin resistance and decreases peripheral glucose clearance.36,37 Altogether, these findings underscore potential associations between CGRP, migraine pathophysiology, and glucose metabolism.38

    what is acceptable blood sugar level glucagon (‚≠źÔłŹ quizlet) | what is acceptable blood sugar level jason funghow to what is acceptable blood sugar level for In a community-based case-control study39 including 1832 participants in China, authors reported increased insulin resistance in individuals with both migraine and prediabetes and an inverse association between type 2 diabetes and migraine. This also is in line with our findings.

    Strengths

    This study has numerous strengths. We evaluated the associations between migraine and type 2 diabetes, updating information of migraine and many covariates during the follow-up period. The prospective design reduces a differential bias in the reporting of migraine episodes associated with the incident type 2 diabetes. The large number of participants and type 2 diabetes cases ensured a high statistical power. Incident cases were identified from an extensive medico-administrative database, which reduced the risk of missing or false-positive cases. The long follow-up time, updated information on migraine, and statistical methodology enabled us to study the evolution of migraine 2-year prevalence from long before type 2 diabetes diagnosis to long after diagnosis, with a possible window of observation of 46 years.

    Limitations

    This study has also some limitations. Migraine was self-reported, and information on the presence of migraine aura was not available. However, the repeated questionnaires over time and the medico-administrative database on drug reimbursements allowed us to isolate associations with both active and prior migraine episodes from associations with antimigraine preparations. However, no information on self-medication was available in this study.

    Type 2 diabetes cases who were not treated pharmacologically were considered as noncases, which could have reduced the magnitude of the observed associations between migraine and type 2 diabetes. However, we believe that this would have a minor influence on the results.

    what is acceptable blood sugar level remission (‚ėĎ brochure) | what is acceptable blood sugar level menuhow to what is acceptable blood sugar level for The E3N cohort is not representative of the general French population because it includes rather homogeneous, health-conscious women. In addition, we have analyzed mainly women in postmenopause. Although this might reduce the variability of certain characteristics and the possibility to extrapolate to the general population and premenopausal women, it should not bias the estimates. Finally, even though we controlled for most established type 2 diabetes risk factors, potential residual and unmeasurable confounding cannot be ruled out completely because this study is observational.

    Conclusions

    Both migraine and type 2 diabetes are highly prevalent diseases. Therefore, these results can have substantial implications on the understanding of mechanisms underlying these 2 conditions. Because plasma glucose concentration rises with time up to the point of type 2 diabetes occurrence, the prevalence of migraine symptoms may decrease. Consequently, tracking the evolution and especially the decrease of migraine frequency in individuals with migraine at high risk of diabetes, such as individuals with obesity, irrespective of age could be the sign of an emerging increased blood glucose levels, prediabetes, or type 2 diabetes.

    We observed a lower risk of type 2 diabetes in women with active migraine. The linear decrease of migraine prevalence long before and the plateau long after type 2 diabetes diagnosis is novel and the association deserves to be studied in other populations. The potential beneficial role of both hyperglycemia and hyperinsulinism on migraine occurrence needs to be further explored.

    Back to top
    Article Information

    Corresponding Author: Guy Fagherazzi, PhD, Center for Research in Epidemiology and Population Health, Institut National de la Sant√© et de la Recherche M√©dicale (INSERM) U1018, Generations and Health, Gustave Roussy Institute, 114 rue Edouard Vaillant, Villejuif Cedex 94805, France ([email protected]fr).

    Accepted for Publication: September 14, 2018.

    Published Online: December 17, 2018. doi:10.1001/jamaneurol.2018.3960

    Author Contributions: Dr Fagherazzi had full access to all of the data in the study and takes responsibility for the integrity of the data for 1 last update 27 May 2020 and the accuracy of the data analysis.Author Contributions: Dr Fagherazzi had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

    what is acceptable blood sugar level jewelry (ūüĎć journal articles) | what is acceptable blood sugar level high blood sugarhow to what is acceptable blood sugar level for Concept for 1 last update 27 May 2020 and design: Fagherazzi, El Fatouhi, Kurth, Bonnet.Concept and design: Fagherazzi, El Fatouhi, Kurth, Bonnet.

    Acquisition, analysis, or for 1 last update 27 May 2020 interpretation of data: Fagherazzi, El Fatouhi, Fournier, Gusto, Mancini, Balkau, Boutron-Ruault.Acquisition, analysis, or interpretation of data: Fagherazzi, El Fatouhi, Fournier, Gusto, Mancini, Balkau, Boutron-Ruault.

    Drafting of the manuscript: Fagherazzi, El Fatouhi, Bonnet.

    Critical revision of the manuscript for important intellectual content: Fagherazzi, Fournier, Gusto, Mancini, Balkau, Boutron-Ruault, Kurth.

    Statistical analysis: Fagherazzi, El Fatouhi, Gusto, Balkau, Kurth.

    Obtained funding: Fagherazzi.

    Administrative, technical, or material support: El Fatouhi.

    Supervision: Boutron-Ruault, Bonnet.

    Other: Mancini.

    Conflict of Interest Disclosures: Dr Kurth reports having contributed to an advisory board of CoLucid and a research project funded by Amgen, for which the Charit√©‚ÄďUniversit√§tmedizin Berlin received compensation; having received honoraria from Lilly for providing methodological advice, from Novartis and Daiichi Sankyo for providing a lectures on epidemiologic methods, and from BMJ for editorial services; and having received travel support from the International Headache Society for being a member of the board of trustees. No other disclosures were reported.

    Funding/Support: The E3N cohort is carried out with the financial support of the ‚ÄúMutuelle G√©n√©rale de l'Education Nationale,‚ÄĚ European Community, French League against Cancer, Gustave Roussy, and French Institute of Health and Medical Research. This present study was also supported by the French Research Agency (Agence Nationale de la Recherche) via an ‚ÄúInvestissement d‚ÄôAvenir‚ÄĚ grant (ANR-10-COHO-0006) that supports the associated E4N study.

    Role of the Funder/Sponsor: The funders/sponsors had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

    Additional Contributions: We thank all participants for providing the data used in the E3N cohort study.

    References
    1.
    Vos  T, Flaxman  AD, Naghavi  M,  et al.  Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010  [published correction appears in Lancet. 2013;381(9867):628].  Lancet. 2012;380(9859):2163-2196. doi:10.1016/S0140-6736(12)61729-2PubMedGoogle ScholarCrossref
    2.
    Burch  RC, Loder  S, Loder  E, Smitherman  TA.  The prevalence and burden of migraine and severe headache in the United States: updated statistics from government health surveillance studies.  Headache. 2015;55(1):21-34. doi:10.1111/head.12482PubMedGoogle ScholarCrossref
    3.
    Scher  AI, Buse  DC, Fanning  KM,  et al.  Comorbid pain and migraine chronicity: the Chronic Migraine Epidemiology and Outcomes study.  Neurology. 2017;89(5):461-468. doi:10.1212/WNL.0000000000004177PubMedGoogle ScholarCrossref
    4.
    Goadsby ¬†PJ, Lipton ¬†RB, Ferrari ¬†MD. ¬†Migraine‚ÄĒcurrent understanding and treatment.¬†¬†N Engl J Med. 2002;346(4):257-270. doi:10.1056/NEJMra010917PubMedGoogle ScholarCrossrefwhat is acceptable blood sugar level variation (ūüĒ• eating) | what is acceptable blood sugar level insulinhow to what is acceptable blood sugar level for
    5.
    Silberstein  SD.  Migraine.  Lancet. 2004;363(9406):381-391. doi:10.1016/S0140-6736(04)15440-8PubMedGoogle ScholarCrossref
    6.
    Pavlovic  JM, Vieira  JR, Lipton  RB, Bond  DS.  Association between obesity and migraine in women.  Curr Pain Headache Rep. 2017;21(10):41. doi:10.1007/s11916-017-0634-8PubMedGoogle ScholarCrossref
    7.
    Pressman ¬†A, Jacobson ¬†A, Eguilos ¬†R, ¬†et al. ¬†Prevalence of migraine in a diverse community‚ÄĒelectronic methods for migraine ascertainment in a large integrated health plan.¬†¬†Cephalalgia. 2016;36(4):325-334. doi:10.1177/0333102415590242PubMedGoogle ScholarCrossref
    8.
    Scher ¬†AI, Terwindt ¬†GM, Picavet ¬†HSJ, Verschuren ¬†WMM, Ferrari ¬†MD, Launer ¬†LJ. ¬†Cardiovascular risk factors and migraine: the GEM population-based study.¬†¬†Neurology. 2005;64(4):614-620. doi:10.1212/01.WNL.0000151857.43225.49PubMedGoogle ScholarCrossrefwhat is acceptable blood sugar level treatment without medication (‚ėĎ in a sentence) | what is acceptable blood sugar level in young childrenhow to what is acceptable blood sugar level for
    9.
    Rist  PM, Winter  AC, Buring  JE, Sesso  HD, Kurth  T.  Migraine and the risk of incident hypertension among women.  Cephalalgia. 2018;38(12):1817-1824. doi:10.1177/0333102418756865PubMedGoogle ScholarCrossref
    10.
    Rist ¬†PM, Tzourio ¬†C, Kurth ¬†T. ¬†Associations between lipid levels and migraine: cross-sectional analysis in the epidemiology of vascular ageing study.¬†¬†Cephalalgia. 2011;31(14):1459-1465. doi:10.1177/0333102411421682PubMedGoogle ScholarCrossrefwhat is acceptable blood sugar level youngest age in pediatrics (‚≠źÔłŹ explained) | what is acceptable blood sugar level numbershow to what is acceptable blood sugar level for
    11.
    Kurth  T, Slomke  MA, Kase  CS,  et al.  Migraine, headache, and the risk of stroke in women: a prospective study.  Neurology. 2005;64(6):1020-1026. doi:10.1212/01.WNL.0000154528.21485.3APubMedGoogle ScholarCrossref
    12.
    Spector ¬†JT, Kahn ¬†SR, Jones ¬†MR, Jayakumar ¬†M, Dalal ¬†D, Nazarian ¬†S. ¬†Migraine headache and ischemic stroke risk: an updated meta-analysis.¬†¬†Am J Med. 2010;123(7):612-624. doi:10.1016/j.amjmed.2009.12.021PubMedGoogle ScholarCrossrefwhat is acceptable blood sugar level hypoglycemia (ūüĒī glucagon) | what is acceptable blood sugar level treatment home remedieshow to what is acceptable blood sugar level for
    13.
    Adelborg  K, Szépligeti  SK, Holland-Bill  L,  et al.  Migraine and risk of cardiovascular diseases: Danish population based matched cohort study.  BMJ. 2018;360:k96. doi:10.1136/bmj.k96PubMedGoogle ScholarCrossref
    14.
    Kurth  T, Gaziano  JM, Cook  NR, Logroscino  G, Diener  H-C, Buring  JE.  Migraine and risk of cardiovascular disease in women.  JAMA. 2006;296(3):283-291. doi:10.1001/jama.296.3.283PubMedGoogle ScholarCrossref
    15.
    Kurth  T, Winter  AC, Eliassen  AH,  et al.  Migraine and risk of cardiovascular disease in women: prospective cohort study.  BMJ. 2016;353:i2610. doi:10.1136/bmj.i2610PubMedGoogle ScholarCrossref
    16.
    McCarthy  LC, Hosford  DA, Riley  JH,  et al.  Single-nucleotide polymorphism alleles in the insulin receptor gene are associated with typical migraine.  Genomics. 2001;78(3):135-149. doi:10.1006/geno.2001.6647PubMedGoogle ScholarCrossref
    17.
    Rainero ¬†I, Limone ¬†P, Ferrero ¬†M, ¬†et al. ¬†Insulin sensitivity is impaired in patients with migraine.¬†¬†Cephalalgia. 2005;25(8):593-597. doi:10.1111/j.1468-2982.2005.00928.xPubMedGoogle ScholarCrossrefwhat is acceptable blood sugar level characteristics (‚≠źÔłŹ mellitus without complication) | what is acceptable blood sugar level carbohydratehow to what is acceptable blood sugar level for
    18.
    Cavestro  C, Rosatello  A, Micca  G,  et al.  Insulin metabolism is altered in migraineurs: a new pathogenic mechanism for migraine?  Headache. 2007;47(10):1436-1442. doi:10.1111/j.1526-4610.2007.00719.xPubMedGoogle ScholarCrossref for 1 last update 27 May 2020
    19.
    Horev  A, Wirguin  I, Lantsberg  L, Ifergane  G.  A high incidence of migraine with aura among morbidly obese women.  Headache. 2005;45(7):936-938. doi:10.1111/j.1526-4610.2005.05162.xPubMedGoogle ScholarCrossref
    20.
    Peterlin  BL, Rapoport  AM, Kurth  T.  Migraine and obesity: epidemiology, mechanisms, and implications.  Headache. 2010;50(4):631-648. doi:10.1111/j.1526-4610.2009.01554.xPubMedGoogle ScholarCrossref
    21.
    Antonazzo  IC, Riise  T, Cortese  M,  et al.  Diabetes is associated with decreased migraine risk: a nationwide cohort study.  Cephalalgia. 2018;38(11):1759-1764.PubMedGoogle ScholarCrossref
    22.
    Burch  RC, Rist  PM, Winter  AC,  et al.  Migraine and risk of incident diabetes in women: a prospective study.  Cephalalgia. 2012;32(13):991-997. doi:10.1177/0333102412453954PubMedGoogle ScholarCrossref
    23.
    Clavel-Chapelon  F; E3N Study Group.  Cohort profile: the French E3N cohort study.  Int J Epidemiol. 2015;44(3):801-809. doi:10.1093/ije/dyu184PubMedGoogle ScholarCrossref
    24.
    Kengne  AP, Beulens  JWJ, Peelen  LM,  et al.  Non-invasive risk scores for prediction of type 2 diabetes (EPIC-InterAct): a validation of existing models.  Lancet Diabetes Endocrinol. 2014;2(1):19-29. doi:10.1016/S2213-8587(13)70103-7PubMedGoogle ScholarCrossref
    25.
    Mancini  FR, Dow  C, Affret  A,  et al.  Micronutrient dietary patterns associated with type 2 diabetes mellitus among women of the E3N-EPIC (Etude Epidémiologique Auprès de Femmes de l’Education Nationale) cohort study.  J Diabetes. 2018;10(8):665-674. doi:10.1111/1753-0407.12654PubMedGoogle ScholarCrossref
    26.
    Bonnet  F, Affret  A, Boutron-Ruault  M-C, Balkau  B, Clavel-Chapelon  F, Fagherazzi  G.  Association between handedness and type 2 diabetes: the E3N study.  Diabetes Care. 2015;38(12):e199. doi:10.2337/dc15-1669PubMedGoogle ScholarCrossref
    27.
    Lipsitz  SR, Kim  K, Zhao  L.  Analysis of repeated categorical data using generalized estimating equations.  Stat Med. 1994;13(11):1149-1163. doi:10.1002/sim.4780131106PubMedGoogle ScholarCrossref
    28.
    Hockaday  JM, Williamson  DH, Whitty  CWM.  Blood-group levels and fatty-acid metabolism in migraine related to fasting.  Lancet. 1971;1(7710):1153-1156. doi:10.1016/S0140-6736(71)91662-XPubMedGoogle ScholarCrossref
    29.
    Marsters  JB, Mortimer  MJ, Hay  KM.  Glucose and diet in the fasting migraineur.  Headache. 1986;26(5):243-247. doi:10.1111/j.1526-4610.1986.hed2605243.xPubMedGoogle ScholarCrossref
    30.
    Critchley  M, Ferguson  F.  Migraine.  Lancet. 1933;221(5708):123-126. doi:10.1016/S0140-6736(00)84315-9Google ScholarCrossref
    31.
    Dexter  JD, Roberts  J, Byer  JA.  The five hour glucose tolerance test and effect of low sucrose diet in migraine.  Headache. 1978;18(2):91-94. doi:10.1111/j.1526-4610.1978.hed1802091.xPubMedGoogle ScholarCrossref
    32.
    Kokavec ¬†A. ¬†Effect of sucrose consumption on serum insulin, serum cortisol and insulin sensitivity in migraine: evidence of sex differences.¬†¬†Physiol Behav. 2015;142:170-178. doi:10.1016/j.physbeh.2015.02.022PubMedGoogle ScholarCrossrefwhat is acceptable blood sugar level remission (‚≠źÔłŹ remission) | what is acceptable blood sugar level reversalhow to what is acceptable blood sugar level for
    33.
    Vollesen  ALH, Snoer  A, Beske  RP,  et al.  Effect of infusion of calcitonin gene-related peptide on cluster headache attacks: a randomized clinical trial.  JAMA Neurol. 2018;75(10):1187-1197. doi:10.1001/jamaneurol.2018.1675PubMedGoogle ScholarCrossref
    34.
    Enr√≠quez-P√©rez ¬†IA, Galindo-Ordo√Īez ¬†KE, Pantoja-Ort√≠z ¬†CE, ¬†et al. ¬†Streptozocin-induced type-1 diabetes mellitus results in decreased density of CGRP sensory and TH sympathetic nerve fibers that are positively correlated with bone loss at the mouse femoral neck.¬†¬†Neurosci Lett. 2017;655:28-34. doi:10.1016/j.neulet.2017.06.042PubMedGoogle ScholarCrossref
    35.
    Li  T-P, Guo  Z, Liu  C-J, Sun  T, Chen  L, Zhao  X.  Association of down-regulation of calcitonin gene-related peptide and substance P with increase of myocardial vulnerability in diabetic neuropathic rats.  Peptides. 2017;96:1-7. doi:10.1016/j.peptides.2017.08.007PubMedGoogle ScholarCrossref
    36.
    Molina  JM, Cooper  GJ, Leighton  B, Olefsky  JM.  Induction of insulin resistance in vivo by amylin and calcitonin gene-related peptide.  Diabetes. 1990;39(2):260-265. doi:10.2337/diab.39.2.260PubMedGoogle ScholarCrossref
    37.
    Abbasi ¬†A, Corpeleijn ¬†E, Postmus ¬†D, ¬†et al. ¬†Plasma procalcitonin is associated with obesity, insulin resistance, and the metabolic syndrome.¬†¬†J Clin Endocrinol Metab. 2010;95(9):E26-E31. doi:10.1210/jc.2010-0305PubMedGoogle ScholarCrossrefwhat is acceptable blood sugar level insulin pump (ūüĒ• carbohydrate) | what is acceptable blood sugar level obesehow to what is acceptable blood sugar level for
    38.
    Siva  ZO, Uluduz  D, Keskin  FE,  et al.  Determinants of glucose metabolism and the role of NPY in the progression of insulin resistance in chronic migraine.  Cephalalgia. 2018;38(11):1773-1781.PubMedGoogle ScholarCrossref
    39.
    Wang  X, Li  X, Diao  Y,  et al.  Are glucose and insulin metabolism and diabetes associated with migraine? a community-based, case-control study.  J Oral Facial Pain Headache. 2017;31(3):240-250. doi:10.11607/ofph.1843PubMedGoogle ScholarCrossref
    X
    .
    ×

    Sign in to access your subscriptions

    Sign in to your personal account
    Institutional sign in: OpenAthens | Shibboleth
    Create a free personal account to download free article PDFs, sign up for alerts, and for 1 last update 27 May 2020 moreto download free article PDFs, sign up for alerts, and more

    Purchase access

    Subscribe to the journal
    Buy this article and get unlimited access and a printable PDF ($30.00) - Sign in for 1 last update 27 May 2020 or create a free accountSign in or create a free account
    Rent this article for read-only access ($8.99)

    Sign in to download free article PDFs

    Sign in to access your subscriptions

    Sign in to your personal account
    Institutional sign in: OpenAthens | Shibboleth
    Create a free personal account to download free article PDFs, sign up for alerts, and more
    what is acceptable blood sugar level is characterized by (‚≠źÔłŹ questions) | what is acceptable blood sugar level mellitus naturehow to what is acceptable blood sugar level for Get free access to newly published articles

    Create a personal account or sign in to:

    • Register for email alerts with links to free full-text articles
    • Access PDFs of free articles
    • Manage your interests
    • Save searches and receive search alerts

    Sign in to access your subscriptions

    Sign in to your personal account
    Institutional sign in: OpenAthens | Shibboleth
    Get free access to newly published articles.
    Create a personal account to register for email alerts with links to free full-text articles.

    Purchase access

    Subscribe to the journal
    Buy this article and get unlimited access and a printable PDF ($30.00) - Sign in or create a free account
    Rent this article for read-only access ($8.99)

    what is acceptable blood sugar level meds (ūüĒ• rise) | what is acceptable blood sugar level symptoms nhshow to what is acceptable blood sugar level for Sign in to save your search

    Sign in to your personal account
    Create a free personal account to access your subscriptions, sign up for alerts, and more

    Purchase access

    Subscribe now

    Sign in to save your search

    Sign in to your personal account
    Create a free personal account to access your subscriptions, sign up for alerts, and more

    Purchase access

    Subscribe to JN Learning for one year

    Sign in to customize your interests

    Sign in to your personal account
    Create a free personal account to download free article PDFs, sign up the 1 last update 27 May 2020 for alerts, customize your interests, and moreto download free article PDFs, sign up for alerts, customize your interests, and more
    Get free access to newly published articles

    Create a personal account or sign in to:

    • Register for email alerts with links to free full-text articles
    • Access PDFs of free articles
    • Manage your interests
    • Save searches and receive search alerts

    what is acceptable blood sugar level prevention (ūüĒ• yoga) | what is acceptable blood sugar level pumps systemhow to what is acceptable blood sugar level for Sign in to make a comment

    Sign in to your personal account
    Create a free personal account to make a comment, download free article PDFs, sign up for alerts and more
    Get free access to newly published articles

    Create a personal account or sign in to:

    • Register for email alerts with links to free full-text articles
    • Access PDFs of free articles
    • Manage your interests
    • Save searches and receive search alerts
    Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "" you are agreeing to our Cookie Policy | Continue